Pneumocystis jirovecii pneumonia in patients with autoimmune disease on high-dose glucocorticoid

Journal of Clinical Rheumatology

Volumn 21, Issue 2, 2015, Pages 72-75

  Chew, Li Ching ^a,b,c   Maceda Galang, Liza Marie ^d   Tan, York Kiat ^a,b,c   Chakraborty, Bibhas ^b   Thumboo, Julian ^a,b,c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d MAKATI MEDICAL CENTER   (Philippines)

Author keywords

Chemoprophylaxis; connective tissue disease; Pneumocystis jirovecii; Pneumocystis pneumonia; steroid

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; GLUCOCORTICOID;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; COMORBIDITY; CORTICOSTEROID THERAPY; DEMOGRAPHY; DRUG MEGADOSE; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; INTENSIVE CARE; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PNEUMOCYSTIS PNEUMONIA; POLYMYOSITIS; PRIORITY JOURNAL; RISK FACTOR; TERTIARY CARE CENTER; AUTOIMMUNE DISEASES; COMPLICATION; MIDDLE AGED; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDY;

ADULT; AGED; ANTI-INFECTIVE AGENTS; AUTOIMMUNE DISEASES; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PREDNISOLONE; RETROSPECTIVE STUDIES; RISK FACTORS; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION;

EID: 84924561764     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0000000000000215     Document Type: Article

References (16)

1. Saito K, Nakayamada S, Nakano K, et al. Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology. 2004;43:479-485.
2. White DA. Drug-induced pulmonary infection. Clin Chest Med. 2004;25:179-187.
3. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350:2487-98.
4. Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases. Arthritis Rheum. 1999;42:780-789.
5. Yale S, Limper A. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: Associated illnesses and prior corticosteroid therapy. Mayo Clin Proc. 1996;71:5-13.
6. Sepkowitz K. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis. 2002;34:1098-1107.
7. Mansharamani NG, Balachandran D, Vernovsky I, et al. Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest. 2000;118: 712-720.
8. Lertnawapan R, Totemchokchyakarn K, Nantiruj K, et al. Risk factors of PCP in patients with SLE. Rheumatol Int. 2009;29:491-496.
9. Stamp L, Hurst M. Is there a role for consensus guidelines for P. jiroveci pneumonia prophylaxis in immunosuppressed patients with rheumatic diseases? J Rheumatol. 2010;37:686-688.
10. Gupta D, Zachariah A, Roppelt H. Prophylactic antibiotic use for Pneumocystis carinii pneumonia in patients with SLE on cyclophosphamide: A survey of US rheumatologists and review of literature. J Clin Rheumatol. 2008;14:267-272.
11. Falagas ME, Manta KG, Betsi GI, et al. Infection-related morbidity and mortality in patients with connective tissue diseases: A systematic review. Clin Rheumatol. 2007;26:663-670.
12. Godeau B, Coutant-Perronne V, Le Thi Huong D. Pneumocystis cainii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol. 1994;21:246-251.
13. Hoffman GS. Treatment of Wegener's granulomatosis: time to change the standard of care? Arthritis Rheum. 1997;40:2099-2104.
14. Porges AJ, Beattie SL, Ritchlin C, et al. Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Rheumatol. 1992;19:1191-1194.
15. Bosch X, Guilabert A, Pallares L, et al. Infections in SLE: A prospective and controlled study of 110 patients. Lupus. 2006;15:584-589.
16. Morris A, Lundgren J, Masur H, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis. 2004;10:1713-1720